.rll-youtube-player .play{--wpr-bg-f58b4a43-de9b-4ea2-ab5f-e49a95044a0b: url('https://www.stocksregister.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-6ddbf23d-bcb6-4d61-a7ef-01df6f897c9c: url('https://www.stocksregister.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Tag: ELEV stock

Companies

Analysts Provide Insight On The Potential For Elevation Oncology Inc (ELEV) To Go High.

Elevation Oncology Inc (NASDAQ:ELEV) price on Thursday, March 20, fall -41.82% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.28. A look at the stock’s price movement, the close in the last trading session was $0.48, moving

Business

Elevation Oncology Inc (NASDAQ: ELEV) Is Down -16.37% Year-To-Date, But Analysts Find Room For A Price Rally

Elevation Oncology Inc (NASDAQ:ELEV) traded at $0.47 at close of the session on Monday, March 10 and made a downward move of -7.89% on its previous day’s price. Elevation Oncology Inc has a market cap of $27.86 million and is expected to release its quarterly

Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.

Tag: ELEV stock

Analysts Provide Insight On The Potential For Elevation Oncology Inc (ELEV) To Go High.

Elevation Oncology Inc (NASDAQ: ELEV) Is Down -16.37% Year-To-Date, But Analysts Find Room For A Price Rally

Quick Links

Categories

All rights reserved ©2024, Powered by Smart TechOne